Aquestive Therapeutics Inc (AQST)
3.12
-0.03
(-0.95%)
USD |
NASDAQ |
May 23, 10:26
Aquestive Therapeutics Total Long Term Debt (Quarterly): 28.78M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 28.78M |
| December 31, 2023 | 27.53M |
| September 30, 2023 | 39.16M |
| June 30, 2023 | 39.16M |
| March 31, 2023 | 42.39M |
| December 31, 2022 | 52.15M |
| September 30, 2022 | 52.90M |
| June 30, 2022 | 53.57M |
| March 31, 2022 | 54.24M |
| December 31, 2021 | 53.58M |
| September 30, 2021 | 40.40M |
| June 30, 2021 | 39.22M |
| March 31, 2021 | 38.06M |
| December 31, 2020 | 36.90M |
| September 30, 2020 | 62.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 61.50M |
| March 31, 2020 | 60.92M |
| December 31, 2019 | 60.34M |
| September 30, 2019 | 59.78M |
| June 30, 2019 | 47.43M |
| March 31, 2019 | 47.59M |
| December 31, 2018 | 47.20M |
| September 30, 2018 | 46.80M |
| June 30, 2018 | 46.43M |
| March 31, 2018 | 45.96M |
| December 31, 2017 | 45.51M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
27.53M
Minimum
Dec 2023
62.10M
Maximum
Sep 2020
47.51M
Average
49.79M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Lifecore Biomedical Inc | -- |
| Harrow Inc | 184.15M |
| Akebia Therapeutics Inc | 30.14M |
| 89bio Inc | -- |
| Humacyte Inc | -- |